M. Cronin

发表

Light-generated oligonucleotide arrays for rapid DNA sequence analysis.

S. P. Fodor, A. C. Pease, D. Solas, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.

M. Cronin, S. Paik, G. Tang, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.

M. Cronin, S. Paik, G. Tang, 2004, The New England journal of medicine.

Universal RNA reference materials for gene expression.

John Quackenbush, John Quackenbush, M. Cronin, 2004, Clinical chemistry.

Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer.

Roman Rouzier, Lajos Pusztai, J. Ross, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comprehensive next-generation cancer genome sequencing in the era of targeted therapy and personalized oncology.

J. Ross, M. Cronin, Jeffrey S Ross, 2011, Biomarkers in medicine.

Cystic fibrosis mutation detection by hybridization to light‐generated DNA probe arrays

S. M. Kim, M. Cronin, R. Fucini, 1996, Human mutation.

Analytical validation of the Oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancer.

M. Cronin, D. Watson, D. Dutta, 2007, Clinical chemistry.

Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing

Alex M. Fichtenholtz, James X. Sun, M. Rubin, 2013, Nature Biotechnology.

Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets.

R. Yelensky, J. Ross, M. Cronin, 2014, Cancer discovery.

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies

Doron Lipson, Hidefumi Sasaki, Roman Yelensky, 2012, Nature Medicine.

Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay.

Debjani Dutta, M. Cronin, S. Shak, 2004, The American journal of pathology.

Tissue handling and specimen preparation in surgical pathology: issues concerning the recovery of nucleic acids from formalin-fixed, paraffin-embedded tissue.

Yanxiang Cao, Stephen M Hewitt, M. Cronin, 2009, Archives of pathology & laboratory medicine.

Estrogen receptor (ESR1) mRNA expression and benefit from tamoxifen in the treatment and prevention of estrogen receptor-positive breast cancer.

Debora Fumagalli, Norman Wolmark, Soonmyung Paik, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic Role of a Multigene Reverse Transcriptase-PCR Assay in Patients with Node-Negative Breast Cancer Not Receiving Adjuvant Systemic Therapy

Kevin Coombes, Massimo Cristofanilli, Sang-Joon Lee, 2005, Clinical Cancer Research.

Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors

P. Stephens, R. Yelensky, M. Cronin, 2013, Genome Medicine.

Effects of epidermal growth factor receptor concentration on tumorigenicity of A431 cells in nude mice.

J. B. Santon, M. Cronin, C. Macleod, 1986, Cancer research.

Effects of epidermal growth factor receptor concentration on tumorigenicity of A431 cells in nude mice.

J. B. Santon, M. Cronin, C. Macleod, 1986, Cancer research.

Technical Advance Measurement of Gene Expression in Archival Paraffin-Embedded Tissues Development and Performance of a 92-Gene Reverse Transcriptase-Polymerase Chain Reaction Assay

M. Cronin, S. Shak, J. Baker, 2003 .

Gene expression profiles of paraffin-embedded core biopsy tissue predict response to chemotherapy in patients with locally advanced breast cancer.

M. Cronin, S. Shak, J. Baker, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic Role of aMultigene ReverseTranscriptase-PCRAssay in Patients with Node-Negative Breast Cancer Not Receiving Adjuvant

K. Coombes, G. Hortobagyi, M. Cronin, 2005 .

EGF induces cell cycle arrest of A431 human epidermoid carcinoma cells

M. Cronin, C. Macleod, J. Mendelsohn, 1986, Journal of cellular physiology.

Optimized RNA extraction and RT-PCR assays provide successful molecular analysis on a wide variety of archival fixed tissues

M. Bronner, M. Cronin, F. Baehner, 2007 .

Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor–Positive Breast Cancer

James X. Sun, P. Stephens, R. Yelensky, 2014, Clinical Cancer Research.

Cancer gene profile of metastatic breast cancer.

G. Mills, P. Stephens, R. Yelensky, 2012 .

Transforming growth factor beta and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection.

M. Cronin, J. McCutchan, W. Wachsman, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Kinase fusions are frequent in Spitz tumours and spitzoid melanomas

Iwei Yeh, Doron Lipson, Thomas Wiesner, 2014, Nature Communications.

Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity.

M. Rubin, P. Stephens, R. Yelensky, 2013, European urology.

Pharmacogenomics: The promise of personalized medicine

M. Cronin, W. Sadee, Wolfgang Sadée, 2000, AAPS PharmSci.

Next generation sequencing of exceptional responders with BRAF-mutant melanoma: implications for sensitivity and resistance

P. Stephens, R. Yelensky, M. Cronin, 2015, BMC Cancer.

Tumor Gene Expression and Prognosis in Breast Cancer Patients with 10 or More Positive Lymph Nodes

M. Cronin, J. Mosquera, S. Shak, 2005, Clinical Cancer Research.

Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissue

M. Cronin, G. Sledge, S. Shak, 2007, Breast Cancer Research and Treatment.

Biomarker discovery for colon cancer using a 761 gene RT-PCR assay

M. Cronin, Chungyeul Kim, J. Baker, 2007, BMC Genomics.

Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer.

Elisabeth Brambilla, Stéphane Vignot, Roman Yelensky, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gene Expression Profiling Utilizing Microarray Technology and RT-PCR

M. Cronin, Mei-lan Liu, D. Sinicropi, 2006 .

Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes.

M. Rubin, P. Stephens, R. Yelensky, 2012, Blood.

A targeted next-generation sequencing assay detects a high frequency of therapeutically targetable alterations in primary and metastatic breast cancers: implications for clinical practice.

P. Stephens, R. Yelensky, L. Pusztai, 2014, The oncologist.

Multi-gene Rt-pcr assay for predicting recurrence in node negative breast cancer patients-nsabp studies B-20 and B-14

Norman Wolmark, Soonmyung Paik, Gong Tang, 2003 .

Whole cancer genome sequencing by next-generation methods.

M. Cronin, Jeffrey S Ross, Maureen Cronin, 2011, American journal of clinical pathology.

Next-generation sequencing identifies and immunohistochemistry confirms a novel crizotinib-sensitive ALK rearrangement in a patient with metastatic non-small-cell lung cancer.

P. Stephens, M. Cronin, F. Hirsch, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Case Presentation Alk Fusions Are Also Associated with Younger Age Next-generation Sequencing Identifies and Immunohistochemistry Confirms a Novel Crizotinib- Sensitive Alk Rearrangement in a Patient with Metastatic Non–small-cell Lung Cancer

P. Stephens, M. Cronin, F. Hirsch, 2012 .

Companion Diagnostics and Cancer Biomarkers Concordance of Genomic Alterations between Primary and Recurrent Breast Cancer

G. Mills, P. Stephens, R. Yelensky, 2014 .

Tests d'hybridation sur des alignements d'oligonucleotides

M. Trulson, M. Cronin, C. G. Miyada, 1997 .

IL-6 production by human T lymphocytes. Expression in HTLV-1-infected but not in normal T cells.

M. Cronin, W. Wachsman, P. Villiger, 1991, Journal of immunology.

Pharmacogenetic Testing

M. Cronin, 2022 .

Concordance of Genomic Alterations between Primary and Recurrent Breast Cancer

Funda Meric-Bernstam, Gordon B Mills, Xiaoping Su, 2014, Molecular Cancer Therapeutics.

Expression of the 21 genes in the Recurrence Score assay and tamoxifen clinical benefit in the NSABP study B-14 of node negative, estrogen receptor positive breast cancer

M. Cronin, S. Paik, G. Tang, 2005 .

Cancer Positive Breast − in Pretreated Advanced Estrogen Receptor Mutations α Emergence of Constitutively Active Estrogen Receptor-Updated

Funda Meric-Bernstam, Rinath Jeselsohn, Lajos Pusztai, 2014 .

Segal and Dowsett , p . 1724 Emergence of Constitutively Active Estrogen Receptor-a Mutations in Pretreated Advanced Estrogen Receptor – Positive Breast Cancer

James X. Sun, P. Stephens, R. Yelensky, 2014 .

Extension of a pilot study: impact from the cytochrome P450 2D6 polymorphism on outcome and costs associated with severe mental illness.

M. Cronin, T. Ryder, M. Pho, 2000, Journal of clinical psychopharmacology.

Tumor marker discovery by expression profiling RNA from formalin fixed paraffin embedded tissues.

M. Cronin, D. Dutta, Mei-lan Liu, 2009, Methods in molecular biology.

Rt-PCR gene expression profiling of RNA from paraffin-embedded tissues prepared using a range of different fixatives and conditions.

M. Cronin, F. Baehner, D. Dutta, 2011, Methods in molecular biology.

RT-PCR-based gene expression profiling for cancer biomarker discovery from fixed, paraffin-embedded tissues.

M. Cronin, Mei-lan Liu, A. Scott, 2011, Methods in molecular biology.

A Targeted Next-Generation Sequencing Assay Detects a High Frequency of Therapeutically Targetable Alterations in Primary and Metastatic Breast Cancers: Implications for Clinical Practice NEILVASAN, a ROMANYELENSKY, b KAIWANG, b STACYMOULDER, c HANNAHDZIMITROWICZ, a RONIAVRITSCHER, c BALIANGWANG, c

P. Stephens, L. Pusztai, M. Cronin, 2014 .

Comprehensive next-generation sequencing for clinically actionable mutations from formalin-fixed cancer tissues.

R. Yelensky, M. Cronin, M. Jarosz, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gene expression markers for breast cancer prognosis of

M. Cronin, S. Shak, J. Baker, 2004 .

Abstract PD02-07: Next-generation sequencing of FFPE breast cancers demonstrates high concordance with FISH in callingHER2amplifications and commonly detects other clinically relevant genomic alterations

R. Yelensky, M. Cronin, M. Jarosz, 2012 .

Abstract S3-6: Profiling of triple-negative breast cancers after neoadjuvant chemotherapy identifies targetable molecular alterations in the treatment-refractory residual disease

R. Yelensky, M. Cronin, H. Gómez, 2012 .

Concordance of driver mutations in primary and matched metastasis from patients with non-small cell lung cancer (NSCLC) using next-generation sequencing (NGS).

P. Stephens, R. Yelensky, M. Cronin, 2012 .

In situ synthesis of oligonucleotide arrays by using surface tension.

J A Walker, K. Anderson, M. Cronin, 2001, Journal of the American Chemical Society.

Abstract 4554: QPCR and sequence analysis of DNA template from a microfluidic CTC isolation platform

M. Cronin, Behrad Vahidi, W. Strauss, 2012 .

A targeted next-generation sequencing assay detects a high frequency of therapeutically targetable alterations in primary and metastatic breast cancers: implications for clinical practice.

P. Stephens, R. Yelensky, L. Pusztai, 2014, The oncologist.

Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity.

M. Rubin, P. Stephens, R. Yelensky, 2013, European urology.